Our understanding of the gut microbiota has significantly evolved over the last two decades. Advances in the analysis of the gut microbiome continues to reveal complex microbial communities and discoveries about their role in health and diseases, including cancer development, are continuously growing. In addition, research has demonstrated that the use of antibiotics can modulate the gut microbiota composition negatively and influence cancer treatment outcomes, suggesting that antibiotics should be avoided if possible. In this article, we review the role of the gut microbiota in the formation of GI cancers. We show that specific bacterial populations can positively or negatively affect cancer formation with specific attention given to gastric and colorectal cancer. We also review the role of microbial-targeted therapies on cancer treatment outcomes.

Antibiotics, the microbiome and gastrointestinal cancers: a causal interference? / Ramai, Daryl; Salati, Massimiliano; Pomati, Giulia; Amoroso, Chiara; Facciorusso, Antonio; Botticelli, Andrea; Ghidini, Michele. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4973. - 67:(2022). [10.1016/j.coph.2022.102315]

Antibiotics, the microbiome and gastrointestinal cancers: a causal interference?

Pomati, Giulia;Botticelli, Andrea
Penultimo
;
2022

Abstract

Our understanding of the gut microbiota has significantly evolved over the last two decades. Advances in the analysis of the gut microbiome continues to reveal complex microbial communities and discoveries about their role in health and diseases, including cancer development, are continuously growing. In addition, research has demonstrated that the use of antibiotics can modulate the gut microbiota composition negatively and influence cancer treatment outcomes, suggesting that antibiotics should be avoided if possible. In this article, we review the role of the gut microbiota in the formation of GI cancers. We show that specific bacterial populations can positively or negatively affect cancer formation with specific attention given to gastric and colorectal cancer. We also review the role of microbial-targeted therapies on cancer treatment outcomes.
2022
microbiome; antibiotics; gastrointestinal cancer; human gut microbiome (GM); inflammatory bowel diseases (IBD); colorectal cancer (CRC)
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Antibiotics, the microbiome and gastrointestinal cancers: a causal interference? / Ramai, Daryl; Salati, Massimiliano; Pomati, Giulia; Amoroso, Chiara; Facciorusso, Antonio; Botticelli, Andrea; Ghidini, Michele. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4973. - 67:(2022). [10.1016/j.coph.2022.102315]
File allegati a questo prodotto
File Dimensione Formato  
Ramai_Antibiotics_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 521.02 kB
Formato Adobe PDF
521.02 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1669227
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact